Axovant Fiscal Q3 Earnings Snapshot
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Slightly above 55% of Sio Gene's investors are presently thinking to get in. The analysis of current outlook of investing in Sio Gene Therapies suggests that some traders are interested regarding Sio Gene's prospects. Sio Gene's investing sentiment can be driven by a variety of factors including economic data, Sio Gene's earnings reports, geopolitical events, and overall market trends.
Sio |
NEW YORK Axovant Sciences Ltd. on Tuesday reported a loss of 4 million in its fiscal third quarter. On a per-share basis, the New York-based company said it had a loss of 5 cents. This story was generated by Automated Insights using data from Zacks Investment Research.
Read at finance.yahoo.com
 |
Sio Gene Fundamental Analysis
We analyze Sio Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Sio Gene is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Sio Gene Therapies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sio Gene stock to make a market-neutral strategy. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics with similar companies.
Peers
Sio Gene Related Equities
| SRZN | Surrozen | 19.37 | ||||
| ALGS | Aligos Therapeutics | 10.96 | ||||
| MNPR | Monopar Therapeutics | 8.84 | ||||
| VINC | Vincerx Pharma | 7.69 | ||||
| CTMX | CytomX Therapeutics | 3.92 | ||||
| VCNX | Vaccinex | 2.44 | ||||
| ASMB | Assembly Biosciences | 1.25 | ||||
| RZLT | Rezolute | 1.00 | ||||
| XOMA | XOMA Corp | 0.84 | ||||
| NUVB | Nuvation Bio | 0.35 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| TARA | Protara Therapeutics | 0.99 | ||||
| SABS | SAB Biotherapeutics | 1.02 | ||||
| TPST | Tempest Therapeutics | 1.04 | ||||
| TIL | Instil Bio | 9.39 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |